India Grants Approval to Takeda’s Dengue Vaccine, First of Its Kind

The surge in dengue cases across the region has been a growing concern

Takeda Pharmaceutical reports an 11-fold increase in dengue cases in India over the past two decades. © Reuters

MUMBAI — India has approved Takeda Pharmaceutical’s dengue vaccine, its first of its kind, to combat the surging spread of the disease. The new authorization marks a critical step in addressing public health challenges posed by the mosquito-borne illness.

Source link